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Abstract
Background: One Health (OH) is an integrated approach, formed inclusive of using multiple disciplines to attain
optimal health for humans, animals, and the environment. The increasing proximity between humans, livestock, and
wildlife, and its role in the transmission dynamics of mycobacterial infections, necessitates an OH approach in the
surveillance of zoonotic diseases. The challenge remains as humans, livestock, and wildlife share resources and
interact at various interfaces. Therefore, this review explores the potential of the OH approach to understand the
impact of mycobacterial infections in Tanzania in terms of lessons learnt and future perspectives.
Materials and methods: Available literature on OH and mycobacterial infections in Tanzania was searched in
PubMed, Google Scholar, and Web of Science. Articles on mycobacterial infections in Tanzania, published between
1997 to 2017, were retrieved to explore the information on OH and mycobacterial infections.
Main body: The studies conducted in Tanzania had have reported a wide diversity of mycobacterial species in
humans and animals, which necessitates an OH approach in surveillance of diseases for better control of infectious
agents and to safeguard the health of humans and animals. The close proximity between humans and animals
increases the chances of inter-specific transmission of infectious pathogens, including drug-resistant mycobacteria.
In an era where HIV co-infection is also the case, opportunistic infection by environmental non-tuberculous
mycobacteria (NTM), commonly known as mycobacteria other than tuberculosis (MOTT) may further exacerbate the
impact of drug resistance. NTM from various sources have greatest potential for diverse strains among which are
resistant strains due to continued evolutional changes.
Conclusion: A collaborative interdisciplinary approach among professionals could help in solving the threats posed
by mycobacterial infections to public health, particularly by the spread of drug-resistant strains.
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Background
The One Health (OH) concept is a recent iteration of
the One Medicine concept that was first established in
the 19th and 20th centuries using the term coined by
Calvin W. Schwabe (1927–2006) [1]. The OH concept
was introduced as a role model in disease surveillance
through an integrated approach adopted by medical,
veterinary, and environmental practitioners. OH is a
deliberate attempt to deviate from the traditional,
narrow-disciplinary approach, to a more holistic, inte-
grated approach that requires multidisciplinary input [2]
and serves as a tool in solving complex issues such as
food safety, microbial resistance to antibiotics, climate
change, and wildlife conservation [3]. This is particularly
important in low-income countries, where resources are
limited, but there is a vast array of issues to address.
The OH concept gained momentum in 2003 during
the avian influenza pandemic threat (HPAI-H5N1) that
killed 339 people and caused a global economic loss of
an estimated USD 20 billion [4]. The lessons learnt from
the HPAI-H5N1 pandemic called for professional collab-
oration in response to emerging and re-emerging infec-
tious diseases at local and international levels [3]. The
Southern African Centre for Infectious Disease Surveil-
lance (SACIDS), a regional consortium of academic and
research institutions in Eastern Africa, in partnership
with academic institutions in South Africa and the United
Kingdom, focuses on the OH concept in response to
emerging and re-emerging infectious diseases at local and
international levels [3]. The African continent faces a
threat from emerging or re-emerging pathogens, infec-
tious diseases of epidemic nature that may occur in en-
demic form, and the persistence of endemic tropical
diseases that are often neglected. Furthermore, consider-
ing that the majority of infectious diseases in humans can
be traced to an animal origin, Rweyemamu et al. [5, 6]
have advocated OH as the most cost-effective approach
for the risk management of infectious diseases in Africa.
Thus, the concept of OH is clearly applicable to mycobac-
terial infections that have gravely threatened human and
animal health at a global level.
This review seeks to address the mycobacterial infection
and challenges associated with its control and diagnosis
through One Health approach. Further, it highlights the
disease situation, lesson learnt and future perspectives in
the control and prevention of mycobacterial infection in
Tanzania.
The OH approach in surveillance of mycobacterial
infections in Tanzania
Disease surveillance using the OH approach has recently
been a subject of immense interest due to the emergence of
infectious diseases that might be caused by close proximity
between animals and humans. The genus Mycobacterium,
consisting of more than 150 well-characterized species, in-
fects both humans and animals [1, 7, 8]. All the members of
this genus appear similar on staining for the detection of
acid-fast bacilli (AFB) [8], are aerobic, non-spore formers,
non-motile, and rod shaped [9, 10]. Mycobacterial infections
have received a great attention due to their ubiquitous distri-
bution and ability to infect a wide range of hosts [1]. Their
widespread nature and importance in public health
emphasize the need for information sharing and active col-
laboration between experts from a variety of disciplines [1].
The tuberculous mycobacteria (M. tuberculosis complex),
comprising of M. tuberculosis, M. bovis, M. bovis BCG, M.
canettii, M. africanum, M. pinnipedii, M. microti, M. caprae,
(the dassie and the oryx bacillus), and the recently discov-
eredM. mungi, are known to be causative agents of tubercu-
losis in animals and humans. However, non-tuberculous
mycobacteria (NTM), also known as environmental myco-
bacteria, have gained importance in recent years due to the
emergence of the Human Immunodeficiency Virus (HIV).
Other mycobacterial species, including M. leprae, M. ulcer-
ans, and M. paratuberculosis, also pose a threat to public
health.
The public health importance of the genus Mycobac-
terium is based on its role as the causative agent of zoo-
notic diseases, including tuberculosis in animals (bovine
tuberculosis) and humans. Katale et al. [11] tested the
hypothesis as to whether the close proximity between
humans and animals might have contributed to the
cross-species transmission of tuberculosis. This hypoth-
esis was driven by anthropogenic changes, which might
have contributed to disease emergence at human-animal
interface areas. Changes in the flow of pathogens due to
anthropogenic changes have direct and indirect effects
on the numbers of susceptible or exposed individuals, or
cause increased infectivity [12]. Recently, studies in the
human-animal interface areas in Tanzania have reported
a relatively low prevalence of bovine tuberculosis (bTB)
in indigenous cattle [11, 13]. However, despite the low
prevalence of bTB in these interface areas, the authors
predicted possibilities for the cross-species transmission
of bTB among the interacting hosts, because of poor know-
ledge among livestock keepers on the transmission dynam-
ics of bTB between wildlife, livestock, and humans [11].
M. tuberculosis is primarily a human pathogen with a
potential for infecting a wide range of hosts, including
wild animals [14, 15] and livestock [16, 17]. In a cross-
sectional study of tuberculosis infection that used the
OH approach at the human-livestock-wildlife interface
of the Serengeti ecosystem, the analysis of the genotype
and phylogeographic distribution of M. tuberculosis
strains isolated from humans revealed a variety of M.
tuberculosis strains with the predominance of a few
successful genotypes, namely, the Central-Asian-strain
(CAS), T, Latin-American-Mediterranean (LAM) and
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East-African-Indian (EAI) families, indicating unlinked
transmission chains [18]. These strains were thought to
result from a gradually evolving M. tuberculosis popula-
tion, rather than from imported strains [19]. This select-
ive predominance of M. tuberculosis strains in Tanzania
seems to co-exist with variations depending on the loca-
tion of the samples within Tanzania. In the Tanga region
of northern Tanzania, the EAI and CAS family geno-
types appear to be predominant [20]. Furthermore, Eld-
holm et al. [19] reported that the human TB epidemic,
that which is caused by a few successful M. tuberculosis
families, is dominated by the CAS family in Dar es Sa-
laam. Other TB strains recorded were LAM (22%) and
EAI (17%). Beijing and T-family genotypes, as well as
importation of strains, were suggested to be a minor
problem. Nevertheless, despite the dominance of the
CAS strain in Dar es Salaam and Tanzania in general,
there were variations in the TB strains within M. tuber-
culosis families [19]. Although the Beijing lineage of M.
tuberculosis has been reported to be found in low pro-
portion [18, 19], its presence is of major concern as it
has been said to be evolutionarily more associated with
drug resistance [21, 22] and presents severe disease
symptoms compared to the other lineages [23]. In
addition, the LAM-TB family genotype, which has also
been found in Tanzania, has been associated with drug
resistance that can be attributed to the genetic back-
ground of particular strains favoring drug resistance or
pre-existing disproportionate exposure to TB drugs of a
particular TB family genotype [24]. The challenge with
drug resistance is the fact that the genetics of observed
drug resistance is more complex than previously ex-
pected [25].
Nearly all the TB strains identified all over the world have
been isolated in East Africa [18], an indication of historical
migrations that have occurred during the pre- and post-
colonial rule. Historical movements due to international
trade, increased movement of wild and domestic animals,
and their interaction has contributed to the global spread
of pathogenic organisms such as M. tuberculosis at an ac-
celerated rate [1, 26, 27]. Likewise, the diversity of M. tuber-
culosis strains in different regions within Tanzania might be
attributed to a cosmopolitan population with frequent
migration and travel [18, 20]. This spread could also be ex-
plained by the ancestral Afro-Asian trade networks existing
from a long time [28].
M. bovis is a multi-host pathogen capable of infecting
a wide range of hosts including humans [29]. Such broad-
spectrum pathogens tend to pose a greater epidemiological
threat than the more specialized ones [30]. In Tanzania,
studies on M. bovis infections in animals have been con-
ducted using the single comparative intradermal tuberculin
test (SCITT) [11, 13, 31–35], gamma interferon assay [36],
and molecular diagnostic techniques such as spacer
oligotyping, mycobacterium interspersed repetitive
units-variable number of tandem repeats (MIRU-VNTR)
[13, 37, 38], and competitive enzyme-linked immunoassay
(ELISA) [39]. The molecular characterization of M. bovis
isolated from the human-animal interface areas indicated
no clear evidence for recent cross-species transmission of
M. bovis between humans, livestock, and wild animals in
Tanzania [37]. However, it was observed that bTB infec-
tions in wild animals and cattle were epidemiologically re-
lated [37]. In a recent study, Katale et al. [37] reported
that M. bovis isolates belonging to the SB0133 spoligotype
isolated from wildlife had 45.2 and 96.8% spoligotype pat-
tern agreement with novel SB2290 and SB2289 strains
from indigenous cattle, respectively [37]. The SB2290
novel spoligotype isolated from indigenous cattle differed
from spoligotypes found in buffalo and African civet by
the loss of a single spacer, indicating the epidemiological
relationship of M. bovis at the livestock-wildlife interface.
This association could mean that wild animals acquire M.
bovis infection from domestic animals rather than vice
versa, as strains with more spacers are evolutionarily older
than those with few spacers. Moreover, it was suggested
that there was a spillback of M. bovis infection from wild
animal reservoirs to livestock, or micro-evolutionary
events of M. bovis in cattle populations in the ecosystem.
It could also be argued that the observed genetic structure
of M. bovis resulted from evolutionary events taking place
in cattle populations outside the study area, possibly
where the prevalence of the disease was higher and that
the M. bovis strains were merely imported into cattle and
wild animal populations in the Serengeti ecosystem [37].
Therefore, wild animals in their ecosystems were at risk of
acquiring M. bovis infection due to occasional interactions
such as sharing of pasture and water sources with live-
stock. Similarly, livestock could acquire infections from
wild animals that may be reservoirs of certain transmis-
sible diseases [13, 40]. In 2013, Mwakapuja and colleagues
found SB1467 to be the dominant spoligotype isolated
from indigenous cattle at the livestock/wildlife interface
areas in the Morogoro region of eastern Tanzania [13].
The authors also found that the SB2190 novel spoligotype
isolated from indigenous cattle was 59.4% related to
SB0133, which was the predominant spoligotype in the
East African countries.
Previous studies conducted in Tanzania had have reported
a variety of atypical mycobacteria in culture isolates from
humans [41, 42] and animals [43, 44], indicating the diver-
sity of NTM species, some of which were capable of causing
diseases in animals and humans. The differences in species
distribution may partly determine the frequency and mani-
festation of pulmonary NTM disease at each geographical
location [45]. In Tanzania, several NTM species, including
M. gordonae, M. interjectum, M. intracelullare, M. sherrisii,
M. avium. spp., and M. fortuitum have been found in
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humans [20, 41, 46], while M. simiae, M. confluentis, M.
neoaurum, M. nonchromogenicum, M. terrae, M. thermore-
sistibile, M. genavense, M. gilvum, M. intermedium, M. pori-
ferae, M. spaghni, M. kansasii, M. gastri, M. indicus pranii,
M. hibernae, M. engbaekii, M. septicum, M. arupense, M.
peregrinum, M. moriokaense, M. palustre, M. goodie, M.
gordonae, M. smegmatis, M. fortuitum, M. phlei, M. flaves-
cens, and M. avium intracellulare have been isolated from
indigenous cattle [34, 41, 44] and M. lentiflavum and M.
intracellulare have been reported in wildlife species [41].
However, Hoefsloot et al. [45] reported that mycobacteria of
the M. avium complex (MAC) were predominant in most
of the countries, followed by M. gordonae and M. xenopi.
Mwikuma et al. [47] also found a diverse range of NTM spe-
cies with a predominance of M. intracellulare, which causes
disease in immunocompromised as well as immunocompe-
tent subjects [48]. The members of NTM induce progressive
pulmonary diseases in older persons, superficial lymphaden-
itis, disseminated disease in severely immunocompromised
patients, and skin and soft tissue infections [49]. In northern
Tanzania, lymphadenitis in TB infections due to NTM was
reported in 31 (47.7%) patients, compared to 7 (10.8%) M.
bovis patients and 27 (41.5%) M. tuberculosis patients [50]. It
is worth mentioning that some of the NTM have potential
health devastating effects [46], both in healthy and immuno-
compromised individuals. For example, invasive NTM infec-
tions due to M. sherrisii and M. avium complex sequevar
M. avium complex-D have been diagnosed in HIV-infected
patients in northern Tanzania [46].
In Tanzania, M. bovis has been isolated from human
in cases of extrapulmonary tuberculosis [38, 50], live-
stock [13, 37, 51] and wildlife [37, 39], signifying threat
of transmission of mycobacteria between livestock, wild-
life and humans in the country. For instance, Mfinanga
and colleagues found high proportion of atypical myco-
bacteria (31 (47.7%) in human as compared to 7 (10.8%)
M. bovis, and 27 (41.5%) M. tuberculosis [50]. Further,
Kazwala et al. [51], in their study in Mbeya region,
Southern Highland Tanzania, investigated a total of 31
M. bovis isolate from cattle and five isolates from hu-
man, of which there was evidence of overlap between
DNA fingerprints of M. bovis between cattle and human.
However, the control and prevention of zoonotic infec-
tions including mycobacteria possess a challenge due to
weak surveillance systems in our local settings attributed
by lack of policies harmonization and limited resources
for diseases control. Therefore, there is need for synergy
of veterinary and medical policies in the control of
tuberculosis in our local settings [51] to optimize the
efforts to ensure there is a better response to disease
threats. Further, governments should increase alloca-
tion of funds for surveillance, control and prevention
of infectious zoonotic diseases to safeguard health for
animals and humans.
Diagnosis and challenges associated with
mycobacterial infections
The accurate diagnosis of mycobacterial species is compli-
cated and an ongoing problem that has passed through a
number of stages, from the testing of drug susceptibility in
the mid–1980s, to use of nucleic-acid probes in the late
1980s, nucleic acid amplification (NAA) in the mid–
1990s, and DNA sequencing at present [8]. The recently
introduced molecular techniques are based on NAA tests
that are used directly on clinical specimens and comple-
mented by blood tests (QuantiFERON-TB, T-SPOT.TB
test) that measure the IFN-γ released by stimulated T
cells. These techniques reduce the time frame for TB diag-
nosis from weeks to days [52]. These newer molecular
methods provide complementary information to conven-
tional diagnostic techniques based on culture and micros-
copy, thus improving patient management [52].
The conventional microscopic examination, culture,
and drug susceptibility testing (DST) of sputum samples
are the most common diagnostic techniques for the de-
tection of the genus Mycobacterium. In many countries,
microscopic examination techniques help in the detec-
tion of M. tuberculosis, culture-based methods are the
cornerstone for diagnosis of TB, and detection of drug
resistant strains is the simplest method for the presump-
tive diagnosis of TB [53]. However, the conventional
microscopic test, which detects the presence of acid-fast
bacilli (AFB), is not useful for the identification of spe-
cies of the genus Mycobacterium. Therefore, there is an
urgent need for highly sensitive, specific, and rapid diag-
nostic techniques that can be performed at the point of
care for the identification of M. tuberculosis and NTM
disease. The WHO emphasizes TB disease to be resist-
ant to pyrazinamide - one of the standard first-line med-
ications used to treat TB with risk for patients being
often misdiagnosed and receiving ineffective treatment
being not uncommon. As such WHO proposes advocacy
on developing strategies to improve food safety, develop-
ing capacity of the animal health sector to reduce the
prevalence of TB in livestock and identification of key
populations and risks pathways for transmission of zoo-
notic TB to break the chain of transmission [54]. Some
NTM are relatively resistant to several of the first- and
second-line TB drugs, thus making the accurate diagno-
sis and drug-susceptibility testing critical for the clinical
management of NTM infection [55]. Timely and accur-
ate identification of TB and NTM diseases could influ-
ence both therapy and epidemiology of TB and TB-like
diseases [20]. The recent advent of whole genome se-
quencing (WGS) has improved our understanding of the
transmission dynamics and identification of mycobacter-
ial infections as well as their drug resistance mutations,
which helps in early identification of the resistance pro-
file of the infecting strain [53]. However, the use of
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WGS in developing countries is limited by factors such
as high running costs and the possibility of its accom-
modation into pre-existing diagnostic frameworks [56].
Thus, several barriers such as high diagnostic costs and
the absence of automated sequence analysis pipelines
and supporting IT infrastructure limit the widespread
adoption of WGS in developing countries [57].
Infections with mycobacteria are subjected to other
challenges, including co-infection with other pathogens,
development of drug resistance, and increased inci-
dences of NTM infections both in immunocompetent
and immunocompromised individuals. Global incidences
of mycobacterial infections have increased in recent de-
cades due to the Human Immunodeficiency Virus (HIV)
pandemic. Co-infection by HIV and TB accelerates the
decline of immunological functions, leading to subse-
quent death if left untreated [58]. HIV infection does
not only increase susceptibility to TB but also predispose
infection to NTM which further complicate TB diagno-
sis. Infections with NTM in AIDS patients are associated
with increased morbidity and high rates of mortality
[59]. In spite of access to active antiretroviral therapy
(ART) for AIDS patients, the concurrent management of
HIV/TB co-infection remains a challenge, due to adverse
effects, drug interactions, and toxicities [60]. Conversely,
the mechanisms leading to the breakdown of the im-
mune defense in HIV-TB co-infected individuals are not
well described [58, 59].
Lessons learnt and future perspective of OH
initiatives in Tanzania
Disease epidemics of zoonotic nature including other agents
than mycobacteria, can better be controlled and managed
through joint OH multidisplinary approach. This has been
learnt in epidemics such as Anthrax, Ebola, rabies and Rift
Valley fever outbreaks where various key player involvement
is necessary to put the situation under custody. The preven-
tion and control of infectious diseases depend on the early
recognition of the causative agents and a prompt response.
Recently, a number of initiatives to address the various as-
pects of infectious disease in humans and animals have been
established in Tanzania. For example, the SACIDS has been
a role model for the surveillance of a variety of infectious
diseases, including mycobacterial infections. It is worth not-
ing that other OH initiatives such as One Health Central
and Eastern Africa (OHCEA) and AfriqueOne have sup-
ported research activities that also focus on infectious dis-
eases of humans and animals in Tanzania. Therefore, to
advocate for the OH approach in disease surveillance, inter-
sectoral collaboration among stakeholders, government
sectors, and society are necessary to address the factors of
health and well-being of humans and animals [61]. In East
Africa, strengthening of the OH networks has been marked
by the establishment of OH coordination units in the
respective countries. This move has gained momentum due
to the status of the East African countries as risk areas for
infectious diseases such as Rift Valley Fever and avian influ-
enza, as well as the detection of Ebola virus in the neighbor-
ing Democratic Republic of Congo (DRC). These OH
coordination units will act as a bridge between the OH
networks and their respective government ministries. For
example, the OH unit established under ‘Disaster Manage-
ment’ in the Prime Minister’s office in Tanzania will serve as
a platform wherein all matters related to OH activities will
be coordinated at all levels to ensure smooth communica-
tion and a rapid response by professionals during periods of
epidemic and inter-epidemic. This is similar to Kenya, where
the Zoonotic Unit linking the human and animal health de-
partments is in place under the Ministries of Health and
Livestock/Agriculture. Similarly, other OH networks have
been established in countries such as India and South Africa,
indicating acceptance of the OH concept in low and middle
income countries [1]. Various regional disease surveillance
programmes have been established for the joint control of
shared disease calamities. For example, regional infectious
disease surveillance bodies, such as the Connecting Organi-
zations for Regional Disease Surveillance (CORDS), were
established in 2010 to improve the interactions between
members and other global partners in order to strengthen
international health security.
Our experience shows that the OH approach brings
healthcare professionals to a common platform that
could improve cooperation during the surveillance of
diseases. This approach could facilitate the implementa-
tion of objectives of OH, through improvement of the
status of the education system, administrative structures,
and legislation [62]. Thus, the infrastructure, as well as
capacity of veterinary and human health facilities, as well
as capacity of facilities should be strengthened to facilitate
the exchange of information between the two sectors. In
addition, the private sector should not be side-lined, but ra-
ther should be considered a partner in sharing the costs in
proportion to the benefits, when distributing responsibility
for emerging pathogens. A smart partnership of SACIDS
and local institutions in Tanzania with external institutions
such as the London School of Hygiene and Tropical Medi-
cine (LSHTM) and the Royal Veterinary College (RVC) in
the United Kingdom, and with the University of Pretoria
and Stellenbosch University in South Africa, has brought
together academicians and researchers to collaborate on
supervision and research activities. This has enabled young
researchers to utilize both local and global facilities for re-
search. The SACIDS, in collaboration with the Sokoine
University of Agriculture (SUA), Muhimbili University of
Health and Allied Sciences (MUHAS), the National Insti-
tute for Medical Research (NIMR), and the Tanzania Wild-
life Research Institute (TAWIRI), has supported the OH
approach and encouraged the shared use of both veterinary
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and human health facilities including laboratories. Training
modules on OH concepts have been established in local
universities to impart inter-disciplinary training on OH to
young scientists. The complex nature of zoonotic diseases
and limited resources in developing countries are reminders
of the need for the implementation of OH in disease
surveillance in low-resource settings [63]. Cost-effective
disease surveillance should be implemented to ensure that
the few resources that are available are streamlined and
synergistically developed between human, animal, and en-
vironmental health in order to prioritize disease control
programs.
Conclusions
In conclusion, the zoonotic importance of mycobacterial in-
fection and the possibility of co-infections with other path-
ogens highlights the need for collaborative efforts among
professionals in terms of sharing of research and resources,
to ensure cost-effective control of diseases. Therefore, it is
important to establish consistent communication among
professionals in order to undertake joint actions toward the
prevention and control of emerging zoonotic diseases in-
cluding mycobacterial infections. Moreover, universities
and research institutions should take a lead to change the
mindset of young scientists to reduce insularity when it
comes to controlling of infectious diseases of public health
importance. It is worth noting that synergy among medical,
veterinary, and environmental professionals in the surveil-
lance of diseases could reduce cost and improve informa-
tion sharing. However, the main concern is whether these
professionals are willing to work on a common platform,
something that might necessitate a change of attitude in
order to achieve the best outcome.
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